Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bora Eldem

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Ophthalmology|August 9, 2020
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic ReviewMali Okada, Paul Mitchell, Robert P Finger, et al.
Ophthalmology|December 15, 2010
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE studyUrsula Schmidt-Erfurth, Bora Eldem, Robyn Guymer, et al.
JAMA Ophthalmology|June 3, 2021
Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular DegenerationMali Okada, Tien Yin Wong, Paul Mitchell, et al.
Acta Ophthalmologica|July 5, 2022
The management of neovascular age-related macular degeneration: A systematic literature review of patient-reported outcomes, patient mental health and caregiver burdenRichard P Gale, Robert P Finger, Bora Eldem, et al.
Plos One|June 4, 2020
Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS studyPaul Mitchell, Tom G Sheidow, Michel E Farah, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 25, 2020
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemicJean-François Korobelnik, Anat Loewenstein, Bora Eldem, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 2, 2021
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressureJean-François Korobelnik, Anat Loewenstein, Bora Eldem, et al.
Eye (London, England)|October 8, 2024
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degenerationKelvin Yi Chong Teo, Bora Eldem, Antonia Joussen, et al.
European Journal of Ophthalmology|August 4, 2022
Expert recommendations for the management of diabetic macular edema with intravitreal dexamethasone implant: A Turkish Delphi studyFigen Batıoğlu, Özge Yanık, Ali Osman Saatçi, et al.
Ophthalmology and Therapy|December 13, 2024
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic StaffFocke Ziemssen, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Ophthalmology|August 9, 2020
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic ReviewMali Okada, Paul Mitchell, Robert P Finger, et al.
Ophthalmology|December 15, 2010
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE studyUrsula Schmidt-Erfurth, Bora Eldem, Robyn Guymer, et al.
JAMA Ophthalmology|June 3, 2021
Defining Nonadherence and Nonpersistence to Anti-Vascular Endothelial Growth Factor Therapies in Neovascular Age-Related Macular DegenerationMali Okada, Tien Yin Wong, Paul Mitchell, et al.
Acta Ophthalmologica|July 5, 2022
The management of neovascular age-related macular degeneration: A systematic literature review of patient-reported outcomes, patient mental health and caregiver burdenRichard P Gale, Robert P Finger, Bora Eldem, et al.
Plos One|June 4, 2020
Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS studyPaul Mitchell, Tom G Sheidow, Michel E Farah, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 25, 2020
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemicJean-François Korobelnik, Anat Loewenstein, Bora Eldem, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 2, 2021
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressureJean-François Korobelnik, Anat Loewenstein, Bora Eldem, et al.
Eye (London, England)|October 8, 2024
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degenerationKelvin Yi Chong Teo, Bora Eldem, Antonia Joussen, et al.
European Journal of Ophthalmology|August 4, 2022
Expert recommendations for the management of diabetic macular edema with intravitreal dexamethasone implant: A Turkish Delphi studyFigen Batıoğlu, Özge Yanık, Ali Osman Saatçi, et al.
Ophthalmology and Therapy|December 13, 2024
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic StaffFocke Ziemssen, Michelle Sylvanowicz, Winfried M Amoaku, et al.
Pageof 5